Xyntha

List of products in the National Drug Code with proprietary name xyntha. This medication is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding. People with low factor VIII levels are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIII, also called antihemophilic factor. This product is used to temporarily replace the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop. This medication should not be used to treat von Willebrand disease.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
58394-012Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-013Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-014Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-015Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-016Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-022Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-023Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-024Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative
58394-025Xyntha Antihemophilic Factor (recombinant)KitWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcPlasma Derivative